Enhanced radioiodine uptake in a patient with poorly differentiated papillary thyroid cancer after treatment with rosiglitazone
Clinical, Cosmetic and Investigational Dermatology vol
[4] Ahmann AJ, Capehorn M, Charpentier G, Dotta F, Henkel E, Lingvay I, Holst AG, Annett MP, Aroda VR
PMCID: PMC6971782
Choosing Semaglutide involves a commitment to regular monitoring appointments with our providers and a willingness to pursue consistent lifestyle modifications including healthy diet and increased physical activity
Clinical trial data from NCT03648554 evaluating dulaglutide based on histological assessment have not been published, and further clinical trials are needed to comprehensively assess the liver benefits of dulaglutide